John Jay Treanor, M.D.

My research interests are primarily focused on control of influenza with vaccines and antivirals, and on the safety and immunogenicity of vaccines for emerging infectious diseases. Our group currently conducts clinical studies evaluating candidate live attenuated influenza vaccines for prevention of pandemic influenza, and studies to document and evaluate the priming effects of pandemic vaccines on subsequent booster vaccines. As director of the New York Influenza Center of Excellence, I collaborate with colleagues in microbiology and immunology to perform detailed evaluations of the human humoral and cellular immune responses to influenza infection and vaccination. Our group is also active in clinical trials to evaluate new vaccines for Norovirus and other viral pathogens in the field and in the human experimental infection model.